Trial Profile
Efficacy and safety of interferon-free therapy in patients with HCV with treatment history of hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Feb 2017
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 13 Feb 2017 New trial record